FALCHETTI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.676
EU - Europa 5.208
AS - Asia 3.087
SA - Sud America 371
AF - Africa 94
OC - Oceania 72
Continente sconosciuto - Info sul continente non disponibili 28
Totale 16.536
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.556
RU - Federazione Russa 1.639
IT - Italia 895
SG - Singapore 876
PL - Polonia 793
CN - Cina 650
HK - Hong Kong 638
SE - Svezia 523
IE - Irlanda 376
VN - Vietnam 325
BR - Brasile 304
DE - Germania 249
UA - Ucraina 237
KR - Corea 210
FR - Francia 148
FI - Finlandia 142
IN - India 118
GB - Regno Unito 111
AU - Australia 70
CA - Canada 62
TR - Turchia 51
JO - Giordania 45
BD - Bangladesh 28
AR - Argentina 26
BE - Belgio 23
IQ - Iraq 23
JP - Giappone 21
PK - Pakistan 20
MX - Messico 19
NG - Nigeria 19
ES - Italia 18
SC - Seychelles 17
ZA - Sudafrica 14
CO - Colombia 12
ID - Indonesia 12
UZ - Uzbekistan 11
CI - Costa d'Avorio 10
JM - Giamaica 10
NL - Olanda 10
CH - Svizzera 9
KE - Kenya 8
MA - Marocco 8
RO - Romania 8
EC - Ecuador 7
EU - Europa 7
IL - Israele 7
SA - Arabia Saudita 7
CR - Costa Rica 6
EG - Egitto 6
GT - Guatemala 6
KZ - Kazakistan 6
BO - Bolivia 5
CL - Cile 5
LT - Lituania 5
UY - Uruguay 5
VE - Venezuela 5
AL - Albania 4
AT - Austria 4
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
IR - Iran 4
AE - Emirati Arabi Uniti 3
CZ - Repubblica Ceca 3
HN - Honduras 3
OM - Oman 3
PS - Palestinian Territory 3
TH - Thailandia 3
TN - Tunisia 3
AO - Angola 2
BG - Bulgaria 2
DM - Dominica 2
DZ - Algeria 2
ET - Etiopia 2
GE - Georgia 2
MM - Myanmar 2
MY - Malesia 2
NP - Nepal 2
PE - Perù 2
PH - Filippine 2
PR - Porto Rico 2
PT - Portogallo 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
GR - Grecia 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LV - Lettonia 1
ML - Mali 1
MU - Mauritius 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
Totale 16.511
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.555
Warsaw 792
Ashburn 670
Fairfield 604
Singapore 554
Hong Kong 549
Chandler 487
Jacksonville 405
Dublin 373
Woodbridge 281
Cambridge 271
Seattle 247
Wilmington 230
Seoul 208
Houston 202
San Jose 201
Milan 176
Beijing 170
Ann Arbor 164
Council Bluffs 124
The Dalles 124
Buffalo 119
Ho Chi Minh City 119
Lawrence 113
Altamura 111
Princeton 97
Hefei 88
Los Angeles 84
Lauterbourg 76
Munich 72
Rome 71
Boardman 68
Boston 66
Melbourne 63
Hanoi 60
Mumbai 56
Medford 55
Moscow 54
New York 51
Shanghai 49
Dallas 46
Florence 43
Paris 41
Kent 38
Pune 32
San Diego 32
Izmir 31
Norwalk 28
Columbus 27
Helsinki 26
Brussels 23
Phoenix 23
São Paulo 23
Naples 22
Tokyo 21
Turku 21
Turin 20
Abuja 16
Baghdad 15
Da Nang 13
Frankfurt am Main 13
Haiphong 13
Palermo 13
Andover 12
Chicago 12
Guangzhou 12
Rio de Janeiro 12
Toronto 12
Brooklyn 11
Frankfurt Am Main 11
London 11
Miano 11
Orem 11
Abidjan 10
Dong Ket 10
Montreal 10
Stockholm 10
Tianjin 10
Verona 10
Bologna 9
Genoa 9
Manchester 9
Tashkent 9
Bern 8
Denver 8
Hillsboro 8
Johannesburg 8
West Jordan 8
Yubileyny 8
Atlanta 7
Auburn Hills 7
Curitiba 7
Falls Church 7
Hải Dương 7
Jakarta 7
Kingston 7
Mexico City 7
Modena 7
Nairobi 7
San Francisco 7
Totale 10.775
Salva come PNG Salva come JPEG
Nome #
Multiple endocrine neoplasia type 1. 358
Multiple Endocrine Neoplasia Type 2. 329
Large-Scale Evidence for the Effect of the COLIA1 Sp1 Polymorphism on Osteoporosis Outcomes: The GENOMOS Study. 327
Segregation of a M404V mutation of the p62/sequestosome 1 (p62/SQSTM1) gene with polyostotic Paget's disease of bone in an Italian family. 286
“Performance Improvements of Gas Injection Plant Using Inlet Air Cooling Systems”, 277
Thyroid cancer: current molecular perspectives. 275
A novel germline inactivating mutation in the CASR gene in an Italian kindred affected by familial hypocalciuric hypercalcemia. 270
Telomerase repeat amplificationprotocol (TRAP): A new molecular marker for parathyroid carcinoma. 227
Characterization and function of the receptor for IGF-I in human preosteoclastic cells. 223
Polymorphisms of the calcitonin receptor gene are associated with bone mineral density in postmenopausal Italian women 220
The regulatory network menin-microRNA 26a as a possible target for RNA-based therapy of bone diseases. 217
FokI polymorphism at translation initiationsite of the vitamin D receptor gene predicts bone mineral density and vertebralfractures in postmenopausal Italian women. 215
Germline mutations in MEN1 and BRCA1 genes in a woman with familial multiple endocrine neoplasia type 1 and inherited breast-ovarian cancer syndromes: a case report. 209
Polymorphism of the Aromatase gene in postmenopausal Italian women: distribution and correlation with bone mass and fracture risk. 206
Analysis of estrogen receptor (ERalpha and ERbeta and progesterone receptor (PR) polymorphisms in uterine leiomyomas. 206
Calcium bioavailability from a calcium-rich mineral water, with some observations on method. 205
AZIDOTHYMIDINE INDUCES APOPTOSIS AND INHIBITS CELL GROWTH AND TELOMERASE ACTIVITY OF HUMAN PARATHYROID CANCER IN CELL CULTURE 204
Multiple endocrine neoplasia type 1 (MEN1): not only inherited endocrine tumors. 197
Allelic variants of human calcitonin receptor: distribution and association with bone mass in postmenopausal Italian women 196
Evidence for bioeffects of LY 139478 on the human pre-osteoclasticcell line FLG 29.1. 196
Allelic loss in parathyroid tumors from individualshomozygous for multiple endocrine neoplasia type 1. 195
A novel recessive mutation of fibroblast growth factor-23 in tumoral calcinosis 195
DNA-based test: when and why to apply it to primary hyperparathyroidism clinical phenotypes 193
A patient with MEN1-associated hyperparathyroidism, responsive to cinacalcet. 193
A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism. 191
ERbeta is a potent inhibitor of cell proliferation in the HCT8 human colon cancer cell line through regulation of cell cycle components 190
Microencapsulation of human parathyroid cells:an "in vitro" study. 190
MEN1 gene mutation analysis in Italian patients with multiple endocrineneoplasia type 1. 187
Multiple endocrine neoplasms 182
The role of osteoprogesterin (OPG) and estrogen receptor (ERα) gene polymorphism. 180
LRP5 gene polymorphism and cortical bone. 179
Construction of a database for the evaluation and the clinical management of patients with breast cancer treated with antiestrogens and/or aromatase inhibitors. 179
Is total parathyroidectomy the treatment of choice for hyperparathyroidism in multiple endocrine neoplasia type 1? 178
Surgical approach in hereditary hyperparathyroidism. 176
Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1. 174
Genome-wide association identifies three new susceptibility loci for Paget's disease of bone. 174
Lessons from genes mutated in multiple endocrine neoplasia (MEN) syndromes. 173
Genetic Epidemiology of Paget's Disease of Bone in Italy: sequestosome1/p62 Gene Mutational Test and Haplotype Analysis at 5q35 in a Large Representative Series of Sporadic and Familial Italian Cases of Paget's Disease of Bone. 172
Telomerase repeat amplification protocol (TRAP): A new molecular marker for parathyroid carcinoma. 172
Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy sindrome (APECED): report on three cases from Southern Italy. 170
Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I. 170
ALLELIC LOSS AT THE VITAMIN D RECEPTOR (VDR) LOCUS IN PARATHYROID TISSUE FROM ONE PATIENT AFFECTED BY REFRACTORY UREMIC HYPERPARATTHYROIDISM 168
Pharmacogenetics of bisphosphonate-associated osteonecrosis of the jaw. 168
Ribozyme-mediated compensatory induction of menin-oncosuppressor function in primary fibroblasts from MEN1 patients. 166
Modulatory effect of farnesyl pyrophosphate synthase (FDPS) rs2297480 polymorphism on the response to long-term amino-bisphosphonate treatment in postmenopausal osteoporosis 166
Mutations In Galnt3 Gene: Two Cases of Tumoral Calcinosis-hyperphosphatemia 166
Osteoporotic patient course after surgical treatment with hip prosthesis 163
Haplotype analysis of two pairs of unrelated Italian families affected by Paget's disease of bone, exhibiting different geographical origins and two different mutations of p62/sequestosomel gene, supports the evidence for common founders. 161
Mutations in GALNT3 GENE: Two adolescents with tumoral calcinosis-hyperphosphatemia 160
Surgery for gastroenteropancreatic tumours in multiple endocrine neoplasia type 1: review and personal experience. 159
The role of osteoprotegerin (OPG) and estrogen receptor (ER-α) gene polymorphisms in rheumatoid arthritis. 159
Paget's disease of bone: there's more than the affected skeletal--a clinical review and suggestions for the clinical practice. 158
Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS study. 158
MEN1 family with a novel frameshift mutation. 157
HPE cells: a clonal endothelial cell line established from human parathyroid tissue (human parathyroid cell line). 156
Molecular diagnosis of parathyroid carcinoma: a reality in the near future. 156
Clonal analysis by chromosome 11 microsatellite-PCR ofmicrodissected parathyroid tumors from MEN 1 patients. 155
Influence of calcium-sensing receptor gene on urinary calcium excretion in stone-forming patients. 153
Somatic mutation analysis of the MEN1 gene in adrenocortical tumors using denaturing gradient gel electrophoresis (DGGE). 152
Dynamic investigation for evaluation of calcium metabolism and parathyroid function. 151
Genetic polymorphisms in uremic secondary hyperparathyroidism. 151
Genetics of osteoporosis: role of steroid hormone receptor gene polymoprhisms. 151
Phytoestrogen: food or drug? 151
Evidence of linkage disequilibrium between polymorphisms in the human estrogen receptor alfa gene and their relationship to bone mass variation in postmenopausal Italian women 151
Progression of uremic hyperparathyroidism involves allelic loss on chromosome 11. 151
CONSENSUS STATEMENT ON DIAGNOSIS OF PRIMARY HYPERCALCIURIA 150
Biological effects of various regimes of 25-hydroxyvitamin D3 (calcidiol) administration on bone mineral metabolism in postmenopausal women 150
Fracture unit: a (possible) model of implementation in Italy. 148
Characterisation of a Non-UBA Domain Missense Mutation of Sequestosome 1 (SQSTM1) in Paget's Disease of Bone. 146
Genetic polymorphisms in uremic secondary hyperparathyroidism. A multicentric Italian study 145
Genetic screening to identify the gene carrier in Italian and German kindreds affected by multiple endocrine neoplasia type 1 (MEN 1) syndrome. 144
Multiple endocrine neoplasia type I variants and phenocopies: more than a nosological issue? 142
Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series. 141
Efficacy of Cinacalcet Therapy In Patients Affected By Primary Hyperparathyroidism Associated To Multiple Endocrine Neoplasia Syndrome Type 1 (men1): Preliminary Results of the Florentine Study 141
Genetic polymorphisms of vitamin D receptor and calcium sensing receptor gene in uremic secondary hyperparathyroidism: a multicentric italian study 140
Genetics and pharmacogenetics of osteoporosis 139
Genetic markers of osteoarticular disorders: facts and hopes. 137
Pancreatectomy in multiple endocrine neoplasia type 1-related gastrinomas and pancreatic endocrine neoplasias 137
Genotype-Phenotype Correlation Analyses in an Italian MEN1 Series. MEN1 Gene Mutational Performed at the Center for Hereditary Endocrine Tumors of Florence 137
Relationship of Volumetric Bone Mineral Density and Structural Parameters with ERα Gene Polymorphisms. 136
GENETICS OF PRIMARY HYPERPARATHYROIDISM 134
Molecular genetic analysis in the diagnosis of humoral calcinosis 127
Production of basic fibroblast growth factor by gastric carcinoid tumors and their putative cells of origin. 124
Genetic aspects of the Paget's disease of bone: concerns on the introduction of DNA-based tests in the clinical practice. Advantages and disadvantages of its application. 124
Genetica dell’Osteoporosi 117
Guidelines for diagnosis and therapy of MEN type 1 and type 2. 117
Osteogenesis Imperfecta: Realization of A Multidisciplinar Network To Improve Information, Expertise and Resources 115
FokI Polymorphisms of the Vitamin D Receptor Gene Correlates with Parameters of Bone Mass and Turnover in a Female Population of the Italian Island of Lampedusa. 111
The vitamin D receptor: biological and molecular properties. 107
Homozygotes for the autosomal dominant neoplasia syndrome (MEN1). 107
RFLP analysis of human chromosome 11 region q13in multiple symmetric lipomatosis and multiple endocrine neoplasia type1-associated lipomas. 107
Gene mutations in Multiple Endocrine Neoplasia Type 1. 104
What Is The Relationship Between Paget’s Disease of Bone and Hyperparathyroidism. 100
Lack of allelic loss at the multiple endocrine neoplasia type 1 (MEN-1) genelocus in a pancreatic ductal (non-endocrine) adenocarcinoma of a patient with theMEN-1 syndrome 98
Hereditary hyperparathyroidism. 97
Results of a national survey on multiple endocrine neoplasia syndrome type1 in Italy: a macroaggregate analysis. 96
Multiple endocrine neoplasia type 2 syndromes (MEN 2): resultsfrom the ItaMEN network analysis on the prevalence of different genotypes and phenotypes. 95
Diagnosis and treatment of Paget's disease of bone: position paper from the Italian Society of Osteoporosis, Mineral Metabolism and Skeletal Diseases (SIOMMMS) 80
Totale 16.536
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.036
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.036
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022593 0 0 31 38 33 21 44 52 25 18 176 155
2022/20231.792 170 385 72 153 144 320 221 74 177 13 42 21
2023/2024618 41 72 103 26 50 89 16 162 6 10 29 14
2024/20254.598 128 460 333 672 1.400 509 101 392 219 121 153 110
2025/20264.075 546 619 269 178 514 182 511 157 212 252 63 572
2026/2027360 134 156 70 0 0 0 0 0 0 0 0 0
Totale 16.536